Rad

In one devastating week, three prominent hardware startups—iRobot, Luminar, and Rad Power Bikes—filed for bankruptcy ... Rad Power Bikes Electric Bicycles Rising costs, inventory glut, and fierce cheap overseas competition.

Edit

Hardware’s Brutal Collapse: iRobot, Luminar, and Rad Power Bankruptcies Expose Industry Crisis

Bitcoin World 19 Dec 2025

In a brutal triple blow, industry giants iRobot, Luminar, and Rad Power Bikes all filed for bankruptcy protection, exposing deep cracks in the hardware startup ecosystem that mirror the volatility we’ve seen in crypto markets.

Edit

AITX's RAD Introduces RAM, the ‘ROSA Accessory Module’, Expanding Agentic AI to Existing 3rd Party Cameras

Nasdaq Globe Newswire 18 Dec 2025

RAM Activates Autonomous Detection, Voice Interaction, and Escalation Through SARA ... .

Edit

AITX’s RAD Introduces RAM, the ‘ROSA Accessory Module’, Expanding Agentic AI to Existing 3rd Party Cameras (Form 8-K) (Artificial Intelligence Technology Solutions Inc)

Public Technologies 18 Dec 2025

AITX's RAD ... Through its next-generation robotic product offerings, AITX's RAD, RAD-R, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business.

Edit

Rad Power Bikes files for bankruptcy protection

The Verge 17 Dec 2025

Rad Power Bikes, the once dominant ... Rad Power lists its estimated assets at $32.1 million and estimated liabilities at $72.8 million.

Edit

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 ...

Nasdaq Globe Newswire 15 Dec 2025

92% of evaluable patients at interim analysis treated with RAD 101 achieved concordance� with MRI imaging (the primary endpoint) with significant and selective tumor uptake in suspected or recurrent brain metastases ... .

Edit

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD

The Eagle-Tribune 15 Dec 2025

92% of evaluable patients at interim analysis treated with RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in suspected or recurrent brain metastases ... .

Edit

Current Report under Regulation A (Form 1-U) (Rad Technologies Inc)

Public Technologies 15 Dec 2025

). UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. FORM 1-U. CURRENT REPORT ... Rad Technologies, Inc ... (State of ... Effective December 1, 2025, the Board of Directors of Rad Technologies, Inc ... RAD TECHNOLOGIES, INC ... Rad Technologies Inc.

Edit

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases (Form 6-K) (Radiopharm Theranostics Ltd)

Public Technologies 15 Dec 2025

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases ... Phase 2b clinical imaging trial of RAD 101 in brain metastases.

Edit

Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market ...

Nasdaq Globe Newswire 12 Dec 2025

.

Podcasts:

Latest News for: rad

AITX Subsidiary RAD-G Moves SARA From Proof of Concept to Paying Agentic AI Clients

A rough week for hardware companies

Seattle e-bike pioneer Rad Power Bikes files bankruptcy, owes $73 million

Sports Wrap with Rad & Hop - Interview with Gus

Hardware’s brutal week: iRobot, Luminar, and Rad Power go bankrupt

Hardware Startups Face Bankruptcy Crisis: Why iRobot, Luminar, and Rad Power Bikes Are Failing

Hardware’s Brutal Collapse: iRobot, Luminar, and Rad Power Bankruptcies Expose Industry Crisis

AITX's RAD Introduces RAM, the ‘ROSA Accessory Module’, Expanding Agentic AI to Existing 3rd Party Cameras

AITX’s RAD Introduces RAM, the ‘ROSA Accessory Module’, Expanding Agentic AI to Existing 3rd Party Cameras (Form 8-K) (Artificial Intelligence Technology Solutions Inc)

Rad Power Bikes files for bankruptcy protection

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 ...

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD

Current Report under Regulation A (Form 1-U) (Rad Technologies Inc)

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases (Form 6-K) (Radiopharm Theranostics Ltd)

Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market ...

Article Search

EXPLORE WN.com